Pharmacist Salary in California 2026,
$164,610 Median | BLS Data by City

California pharmacists earn a median $164,610 a year, $79.14 an hour, per BLS OEWS May 2025. The range runs $90,560 to $213,820, but the 25th percentile is $138,360, so the bottom of that range represents part-time and relief work rather than a full-time career stage. Most full-time California pharmacists earn between the 25th and 75th percentiles.

Napa pays the most at $200,580, followed by San Jose-Sunnyvale-Santa Clara at $199,040, San Francisco-Oakland-Fremont at $177,410, San Luis Obispo-Paso Robles at $172,860 and Sacramento-Roseville-Folsom at $172,680. The pattern rewards integrated health systems and biotech corridors, and small high-cost markets that struggle to staff, rather than metro size.

Graduate from an ACPE-accredited PharmD programme, complete the required intern hours, and pass both the NAPLEX and the California Practice Standards and Jurisprudence Examination administered under the California State Board of Pharmacy. California does not offer licensure transfer by score transfer the way most states do, so pharmacists moving here from another state still sit the California jurisprudence exam.

It is at the top of the group but not alone. Alaska is close at $167,310, Oregon at $165,960, Hawaii at $163,220, Washington at $160,610 and Minnesota at $159,740. What separates California is depth of demand: it has the retail, health-system and biotech sectors all hiring the same licence, where the other states in that group are usually strong in one of the three.

Retail chain staff roles and health-system staff roles pay broadly similarly at the median in this state. The divergence comes later: health-system practice has a clinical specialty and management ladder that reaches the 75th and 90th percentiles, while retail's ladder tops out at pharmacy manager for most practitioners. Biotech and industry roles pay at the top of the range but hire a small number of pharmacists.

Because the bottom decile of this series is not a career stage, it is an employment pattern. Relief, per-diem and part-time pharmacists appear in the wage data at their actual annual earnings, which pulls the 10th percentile down to $90,560 while the 25th percentile sits at $138,360. Read the 25th percentile, not the 10th, as the realistic floor for full-time California practice.

Less than expected to the median, more than expected to the experience of the job. Chain closures have removed posts, but they have also removed the lowest-paying ones and pushed staffing ratios in the remaining stores, so the pay figure has held while workload complaints have risen. The pharmacists who benefited moved into health-system and ambulatory roles, which is where the 75th percentile sits.

California pharmacists can initiate several categories of therapy under statewide protocol and bill for some clinical services, which supports ambulatory-care and clinic-based roles that simply do not exist in more restrictive states. That is a structural reason to expect the California figure to stay above the national one rather than a temporary shortage effect.